Clinical Trials Search

Department: Cardiology
Diagnosis: Cardiac - Acute Coronary Syndrome
Principal Investigator: Kaluski MD, Edo
Sponsor: Zoll
Details (Identifier #): NCT01446965
Title: Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator
Department: Cardiology
Diagnosis: Cardiac - Arrhythmia
Principal Investigator: Deshmukh MD, Pramod
Sub-Investigator(s):
  • Hackett CRNP, Vera
Sponsor: St. Jude Medical
Details (Identifier #): NCT02548455
Title: A Clinical Evaluation of the Safety of the St. Jude Medical Quartet 1457Q Left Ventricular Lead, an Investigational Device Exemption (IDE) Study
Department: Oncology
Diagnosis: Lung- Non-Small Cell
Principal Investigator: Walsh MD, James
Sub-Investigator(s):
Sponsor: OncoCyte
Title: ONC-LN-04, A study to Evaluate a Panel of Blood Biomarkers for Use in Patients Undergoing Evaluation for Lung Cancer
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Thakar MD, Keyur
Sponsor: NCI
Details (Identifier #): NCT02502266
Title: Protocol NRG-GY005,A Randomized Phase II/III study of the combination of Cediranib and Olaparib compared to Cediranib or Olaparib alone, or Standard of care chemotherapy in women with recurrent platinum-resistant or -refractory ovarian, fallopian tube, or primary peritoneal cancer (COCOS)
Department: Oncology
Diagnosis: Oncology - General
Principal Investigator: Thakar MD, Keyur
Sponsor: NCI
Details (Identifier #): NCT02446600
Title: NRG-GY004, A Phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.